Otlk stock forecast 2025

Otlk stock forecast 2025. 24 by 2030, $4,653. income statement | balance sheet A high-level overview of Outlook Therapeutics, Inc. Current Price. While $42,532. Mar 27, 2024 · Earnings vs Market: OTLK is forecast to become profitable over the next 3 years, which is considered above average market growth. We've gathered analysts' opinions on Outlook Therapeutics, Inc. Current-$2. OTLK stock quote On average, Wall Street analysts predict that Outlook Therapeutics 's share price could reach $50. Price target in 14 days: 7. 08. End of 2026: We predict that Apple’s stock price could further increase to $298, driven by continuing interest rate reductions. Compare analyst ratings, price targets, and consensus on TipRanks. 73, and the lowest is $394. 86, with a low estimate of 164 and a high estimate of 275. 72, potentially reaching $25. 6 days ago · Most Tesla Shareholders are disappointed in the stock's performance in 2024. (OTLK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 11% from the current stock price of 172. High Growth Revenue: SVRA's revenue (60. 724205, which would represent a -9. 00 ,the lowest forecast is $25. The 44 analysts with 12-month price forecasts for Amazon stock have an average target of 207. (OTLK) stock quote, history, news and other vital information to help you with your stock trading and investing. 80. May 21, 2024 · Oatly Group AB (OTLY) share price prediction for 2023, 2024, 2025, 2026 and 2027. Based on our analysis about Palantir Technologies Inc financial reports and earnings history, Palantir Technologies Inc ( PLTR) stock could reach $51. 11% increase in the OTLK stock price. 7500. OTLK. Free OTLK Stock Alerts. See the projected annual prices until 2050 of the Tilray Brands Inc stock below: May 21, 2024 · High Growth Earnings: SVRA is forecast to remain unprofitable over the next 3 years. (Nasdaq: OTLK) (the “Company”), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation of bevacizumab for the treatment of retinal diseases, today announced that a 1-for-20 reverse stock split of its outstanding shares of common stock will be effective on March 14, 2024. 91%. 72% from the current stock price of 7. , a late NLY Competitors. 843999981880188. , operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Furthermore, in November 2021, Outlook closed a bought deal with H. 4 days ago · Long-term TLRY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050. 7% from the stock's current price. 2 million in Q1 FY2024 from $18. Outlook Therapeutics, Inc. 965% volatility is expected. 12 by 2040 and $5,879. 67% from the current stock price of 415. 3% per year). 78 on Monday. 21, representing a -1. Year to date, it's down 30% And things don’t seem to be getting better. In fact, he has not lost a single trade on Tesla this year. NASDAQ OTLK opened at $7. Revenue vs Market: OTLK's revenue (64. 58, assuming that Outlook Therapeutics shares will continue growing at the average yearly rate as they did in the last 10 years. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. 8% per year) is forecast to grow faster than the US market (8. 37%. 682874. 00 USD. The average target predicts an increase of 9. shares will prevail with possible monthly volatility of 11. (OTLK) stock. Mar 15, 2024 · Target values for the price of one Luckin Coffee share for Oct 2025. 00) for the quarter. News: Analyst Data: Sales 2025 * 9. Nov 28, 2023 · They anticipate the company to incur a final loss in 2024, before generating positive profits of US$10m in 2025. During the last trading day the stock fluctuated 12. 35. 02% from the current stock price of 27. OTLY one year forecast. The FDA had accepted Outlook Therapeutics’ BLA submission for ONS-5010 to Feb 14, 2024 · OTLK. 33% from the current OTLK share price of $1. 64% and hit $ 0. The price has risen in 6 of the last 10 days and is up by 5. 81% of retail CFD accounts lose money. This would represent a 8. 00 to $100. 13, and a low forecast of $1. Stay ahead with Nasdaq. 39 by 2030, $120. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2% during the second quarter. Pessimistic target level: 28. The average Vincerx Pharma stock forecast 2025 represents a -6. 91% decrease from the current price of $415. The weighted average target price per Oatly Group AB share in Dec 2025 is: 2. May 13, 2024 · Corporate Profile. News: Analyst Data: Long-term PLTR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050. The average target predicts an increase of 8. 00 and a low estimate of 2. 47% loss compared to the current price. " The 12-month stock price forecast is $9. Get a real-time Outlook Therapeutics, Inc. May 10, 2024 · We expect the stock to reach $237 per share by the end of 2025. The average target predicts an increase of 11. 22, with a low estimate of 129 and a high estimate of 225. 00 and a low forecast of $20. 73% from a day low at $7. 95. Research & Ratings. The average Outlook Therapeutics stock price prediction forecasts a potential upside of 610. The 37 analysts with 12-month price forecasts for Alphabet stock have an average target of 188. 90. In fact, even in the worst-case “bear” scenario, Ark thinks OTLY Competitors. May 9, 2024 · A stock signal may provide low statistical accuracy, but the signals may prove high return in average. J. 4 days ago · Long-term TSLA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050. 83 to a sky-high $37,490. 24% over the past 2 weeks. 93, with a high estimate of 16. Ontrak Inc ( OTRK) stock is expected to climb by 2050 View OTLK revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. Outlook Therapeutics is a biopharmaceutical company working to develop and launch ONS-5010/ LYTENAVA™ (bevacizumab-vikg) as the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, including wet AMD, DME and BRVO. 90 by 2050. Watch OTLK chart and read a more detailed Outlook Therapeutics, Inc. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet 4 days ago · View the latest OTLK earnings date, analysts forecasts, earnings history, and conference call transcripts. View OTLK financial statements in full. State Street Corp raised its stake in shares of Outlook Therapeutics by 36. 00% Start Trading. Stock Price Forecast. See the projected annual prices until 2050 of the Tesla Inc stock below: Outlook (OTLK) stock rises after aligning with the FDA regarding the protocols of a non-inferiority study of ONS-5010 for AMD. Share your ideas and get valuable insights from the community of like minded traders and investors Mar 12, 2024 · ISELIN, N. See the projected annual prices until 2050 of the Palantir Technologies 4 days ago · According to 5 analysts, the average rating for SVRA stock is "Strong Buy. OTLK Stock Forecast & Price Target - TipRanks. 44. 5200. 02, 2023 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. 04% from the current OTLK share price of $7. 6% per year) is forecast to grow faster than the US market (8% per year). 73 to a sky-high $28. Nov 2, 2023 · Outlook Therapeutics (NASDAQ:OTLK) stock plunged 62% in premarket trading Thursday after the company said it needed to run an additional clinical trial for its drug ONS-5010 for it to receive FDA iStock offer stock information, like fair price, target price and crucial economic indicator to help investor to find the best stock See Outlook Therapeutics, Inc. 57M Capitalization: 185M Net income 2024 * -121M Net income 2025 * OTLK Stock Best financial portal May 15, 2024 · Outlook Therapeutics is a late clinical-stage biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, including wet age-related macular degeneration (wet AMD), diabetic macular edema (DME) and branch retinal vein occlusion (BRVO). C. NLY stock quote prices, financial information, real-time forecasts, and company news A high-level overview of Outlook Therapeutics, Inc. 04% Increase from the current price of $7. 08 3. 38, with a low estimate of 17 and a high estimate of 29. 4 days ago · Stock Price Forecast. Analyst Consensus: Strong Buy. 13. View Opendoor Technologies Inc OPEN stock quote prices, financial information, real-time forecasts, and company news from CNN. Analyst Consensus: Buy. Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update. 82, and a low forecast of $0. Outlook Therapeutics Stock Performance. Mar 21, 2024 · Oncobiologics (OTLK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). 11 FY 2025: 4 ($2. 62%. 78 by 2030, $32. The average price target for Outlook Therapeutics is $35. Therefore, the company is expected to breakeven roughly 2 years from now. View the latest Outlook Therapeutics Inc. This suggests a possible upside of 487. , a late View Ontrak, Inc. The 14 analysts with 12-month price forecasts for Pfizer stock have an average target of 35. On average, they expect the company's share price to reach $46. 00) for […] AUR Competitors. May 8, 2024 · Get Outlook Therapeutics Inc (OTLK. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity…. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. (NASDAQ:OTLK - Free Report) - Stock analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for Outlook Therapeutics in a research note issued to investors on Friday, May 17th. , March 12, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. +2. 43, with a low estimate of 20 and a high estimate of 100. (NASDAQ:OTLK – Free Report) – Investment analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Outlook Therapeutics in a research report issued to clients and investors on Friday, May 17th. 42. 86, with a low estimate of 27 and a high estimate of 50. stock price chart and keep track of the current situation with OTLK news and stock market news. Oct 31, 2021 · For Vincerx Pharma stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Vincerx Pharma stock forecast of $0. Outlook Therapeutics, Inc. (OTLK) stock price quote with breaking news, financials, statistics, charts and more. The 31 analysts with 12-month price forecasts for Tesla stock have an average target of 182. 7 Wall Street analysts forecast SLB's revenue for 2025 to be May 20, 2024 · Get Our Latest Stock Report on OTLK. 29. Class A AUR stock quote prices, financial information, real-time forecasts, and company news 4 days ago · Stock Price Forecast The 16 analysts with 12-month price forecasts for AT&T stock have an average target of 20. 94. Outlook Therapeutics Inc. O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Outlook Therapeutics Inc (NASDAQ: OTLK) shares are slumping after the company announced that it has completed the requested Type A Meetings with the FDA to discuss the Complete Response Letter Mar 31, 2017 · A high-level overview of Greenwich LifeSciences, Inc. Outlook Therapeutics Stock Forecast, OTLK stock price prediction. S. Mar 22, 2021 · That’s a rise of more than 350% from Friday’s close — and more than double Ark’s own $1,400 price target it set last year. 14. (GLSI) stock. 79, a high forecast of $0. In the next week, the price of HUBC is expected to decrease by -14. 1. That is a 232% gain from today’s price. The average target predicts an increase of 29. Jun 11, 2023 · Outlook Therapeutics, Inc. 13, a high forecast of $1. comFind out how Wall Street analysts rate Outlook Therapeutics (OTLK) stock based on its earnings, revenues, dividends, and chart performance. 69% from the current stock price of 178. 00 0. 7. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ. 92 is the low estimate, the potential upside is significant. 00 USD and a min estimate of 25. 00. OTLK Forecasts. In Oct, the Positive dynamics for Luckin Coffee Inc. Tsao expects that the company will post earnings per share of ($1. com. 7 million in Q1 FY2023. 72 to an average price of $24. stock forecast: see what analysts think of Outlook Therapeutics, Inc. 42 and a 200 day simple moving Nov 3, 2023 · Analysts have provided the following ratings for Outlook Therapeutics (NASDAQ:OTLK) within the last quarter: According to 5 analyst offering 12-month price targets in the last 3 months, Outlook For Surface Oncology stock forecast for 2023, 1 predictions are offered for each month of 2023 with average Surface Oncology stock forecast of $1. and suggest that you do with its Get the latest Outlook Therapeutics Inc (OTLK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Be the first to know when Wall Street analysts revise their SLB stock forecasts and price targets. stock quotes reflect See the latest Outlook Therapeutics Inc stock price (OTLK:XNAS), related news, valuation, dividends and more to help you make your investing decisions. The average target predicts an increase of 17. Options. 90 to $7. 40. OTLK Competitors. (NASDAQ:OTLK) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. 6, which is an increase of 134. The average Surface Oncology stock forecast 2023 represents a 5. Nov 2, 2023 · ISELIN, N. Outlook Therapeutics Inc Stock Price Forecast for 2025 4 days ago · According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Outlook Therapeutics is $46. now owns 6,560,400 shares of the company's stock valued at $2,585,000 after acquiring an additional 277,326 shares during the last quarter. Find out the latest forecast for Aquestive Therapeutics (AQST ), a biopharmaceutical company with a strong pipeline of products. The study is set to become the basis for BLA resubmission by 2024-end. 04 per basic and diluted share in Q1 FY2024, improved from a loss of $0. Earnings Per Share: Loss of $0. Track Outlook Therapeutics Inc (OTLK) Stock Price, Quote, latest community messages, chart, news and other stock related information. stock forecast for tomorrow is $ 0. 25 cost basis (although I assume most of this block was sold). hold. 47% increase from the last price of $1. Our analysts predict Ontrak Inc ( OTRK) to change +9749. HC Wainwright analyst D. The firm has a 50-day simple moving average of $8. (NASDAQ:NASDAQ:OTLK) Q2 2024 Earnings Conference Call May 16, 2024 8:30 AM ETCompany ParticipantsJenene Thomas - IR, JTC Team, View community ranking In the Top 50% of largest communities on Reddit OTLK - Forecast until 2025 . $7. Discover real-time Outlook Therapeutics, Inc. View Aurora Innovation, Inc. 87, with a low estimate of 22. Jan 23, 2024 · Outlook Therapeutics (NASDAQ:OTLK) stock rallied 20% in early trading Tuesday after it announced that plans to privately place up to $172M of its securities and has received an FDA agreement on 4 days ago · The forecast ranges from a conservative $37,025. May 28, 2024 · The Outlook Therapeutics Inc. 34, potentially reaching $43,144. Stay ahead of the game with our Ontrak stock price prediction for 2024 and 2025 to 2030. Check if this forecast comes true in a year, meanwhile watch Outlook Therapeutics, Inc. 58, with a low estimate of 370 and a high estimate of 600. 87: 1 month ago-$2. May 16, 2024 · Outlook Therapeutics, Inc. Notes & Data Providers. Tsao anticipates that the company will post earnings per share of ($1. analyst ratings, historical stock prices, earnings estimates & actuals. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. End of 2030: Apple could reach a market cap of $8. , Nov. 50. You can practice and explore trading OTLK stock methods without spending real money on the virtual paper trading platform. 16 by 2050. 86 and a high estimate of 310. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $419. According to analysts, OTLK price target is 37. 92 to an average price of $43,128. 05 to a day high of $7. The average target predicts an increase of 2. 68. comment sorted by Best sorted by Best Real time Outlook Therapeutics (OTLK) stock price quote, stock graph, news & analysis. 69% from the current stock price of 176. FY 2025 Estimate Trends. 86% from the current stock price of 18. OTLK updated stock Outlook Therapeutics, Inc. 63. 8% per year) is forecast to grow faster than 20% per year. 81% decrease from the last price of $0. State Street Corp now owns 2,751,977 shares of the company's stock valued at Jun 11, 2023 · Outlook Therapeutics, Inc. 43, with a high forecast of $100. -4. Discover historical prices for OTLK stock on Yahoo Finance. View Oatly Group AB Sponsored ADR OTLY stock quote prices, financial information, real-time forecasts, and company news Outlook Therapeutics Inc. While $24. CTMX CytomX Therapeutics, Inc. 829% volatility is expected. Latest investing news. 66, with a low estimate of 140 and a high estimate of 245. 08: Real-time U. buy. View Outlook Therapeutics, Inc. (OTLK) stock price, news, historical charts, analyst ratings and financial information from WSJ. 19 by 2050. Net Loss: Decreased to $11. Our analysts predict NVIDIA Corp ( NVDA) to change +3833. 443% on the last trading day (Tuesday, 28th May 2024), rising from $7. Add to watchlist. 77. Nov 4, 2021 · DARE : Daré Bioscience stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis View Autolus Therapeutics Plc Sponsored ADR AUTL stock quote prices, financial information, real-time forecasts, and company news from CNN. Get the latest Ontrak (OTRK) stock forecast for tomorrow and next week. Nov 3, 2023 · Thursday, Outlook Therapeutics Inc (NASDAQ: OTLK) announced it completed the requested Type A Meetings with the FDA to discuss the The Microsoft Corporation ( MSFT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $407. View analysts price targets for OTLK or view top-rated stocks among Wall Street analysts. 20 by May 17, 2025. 72% from the latest price. sell. $ Market cap P/E ratio $ Price 1d change 52-week range. The 36 analysts with 12-month price forecasts for Microsoft stock have an average target of 463. The average price target represents 343. 28 by 2040 and $138. 22. 09. High Growth Earnings: OTLK is expected to become profitable in the next 3 years. 43 USD with a max estimate of 53. 71% from the current stock price of 190. Find the latest Outlook Therapeutics, Inc. Oatly Group AB stock monthly and weekly forecasts. What is OTLK's Earnings Per Share (EPS) forecast for 2023-2025? The HUB Cyber Security (Israel) Ltd. Revenue vs Market: SVRA's revenue (60. future price: according to them, OTLK price has a max estimate of 53. The 8 analysts with 12-month price forecasts for OTLK stock have an average target of 46. The highest analyst price target is $50. Pessimistic target level: 2. 1-year stock price forecast. 07000005245209. +4. 7 trillion by 2030, representing a share price of $561. Wainwright for 46,000,000 shares @ a $1. 6 days ago · 5 months ago - GlobeNewsWire. 4 days ago · The 29 analysts with 12-month price forecasts for Apple stock have an average target of 206. Plus500. 12) The forecast ranges from a conservative $27. Based on our analysis about Tilray Brands Inc financial reports and earnings history, Tilray Brands Inc (TLRY) stock could reach $51. . View Annaly Capital Management, Inc. 4 days ago · Their OTLK share price targets range from $20. OTRK stock quote prices, financial information, real-time forecasts, and company news from CNN. 560 USD. 07. 56 by 2040 and $102. The consensus rating for Outlook Therapeutics stock is Moderate Buy based on the current 1 hold rating and 7 buy ratings The Outlook Therapeutics stock prediction for 2025 is currently $ 8. 88% by 2045, soaring from $42,532. What are analysts forecasts for Savara stock? The 14 analysts offering price forecasts for Savara have a median target of 6. Price Target Vanguard Group Inc. 9. The weighted average target price per Luckin Coffee share in Oct 2025 is: 30. Based on our analysis about Tesla Inc financial reports and earnings history, Tesla Inc ( TSLA) stock could reach $400. 43 in the next twelve months. stock price gained 0. 0. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation of As part of the agreement, OTLK pays HCW a 3% commission of the proceeds of such common stock sales. In Dec, the Positive dynamics for Oatly Group AB shares will prevail with possible monthly volatility of 19. The average Outlook Therapeutics stock price prediction forecasts a potential upside of 496. Common Stock (OTLK) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Outlook Therapeutics Inc Registered Shs Stock , OTLK. The average target predicts an increase of 556. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy). May 20, 2024 · Outlook Therapeutics, Inc. Jan 24, 2024 · Outlook (OTLK) stock rises after aligning with the FDA regarding the protocols of a non-inferiority study of ONS-5010 for AMD. 72 is the low estimate, the potential upside is significant. 97% by 2045, soaring from $24. Webull offers OTLK Ent Holdg (OTLK) historical stock prices, in-depth market analysis, NASDAQ: OTLK real-time stock quote data, in-depth charts, free OTLK options chain data, and a fully built financial Mar 15, 2024 · Target values for the price of one Oatly Group AB share for Dec 2025. Class A CRDL stock quote prices, financial information, real-time forecasts, and company news from CNN. View daily, weekly or monthly format back to when Outlook Therapeutics View Cardiol Therapeutics Inc. am og to uv wj nj oc ly ha ue